Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Orbio Logo
Orbio CB Rank
492842
Heat Score
69
Orbio is a medical industry that conducts research and development in the field of cancer treatment and diagnosis with L-glucose.
Founded
obfuscation
Private Kyoto, Kyoto, Japan1-10 orbio.jp/
Health Diagnostics
Medical
Therapeutics
Overview

Orbio
Heat Score
69

Growth Score
pts
in past quarter
Heat Score 69
-20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Orbio

CB Rank
492842
Orbio is a medical industry that conducts research and development in the field of cancer treatment and diagnosis with L-glucose.
Founded
obfuscation
Private Kyoto, Kyoto, Japan1-10 orbio.jp/
Health Diagnostics
Medical
Therapeutics

Details

Legal Name Orbio Co., Ltd.
Also Known As Oncotherapy Revolution By Isomer Organics, ORBIO Corporation, オルバイオ
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

L-Glucose Bound Orbio-Molecules
Anti-cancer drug candidates using L-glucose molecules that selectively target cancer cells for treatment of intractable cancers.
L-Glucose Based Drug Delivery System (DDS) for Cancer-Specific Cell Therapy
A drug delivery system using L-glucose to achieve high selectivity in delivering therapeutic agents specifically to cancer cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Active Website Tech Count

23Orbio is actively using 23 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Apple Mobile Web Clips Icon, and  Euro.

Total IP

10The intellectual property of Orbio includes 10 registered patents primarily in the 'Testing' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Orbio's headquarters? Orbio is located in Kyoto, Kyoto, Japan.Who are Orbio's competitors? Alternatives and possible competitors to Orbio may include Lisata Therapeutics, Plus Therapeutics, and  Halozyme Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|